Table 1.
Calculation method | Degree | MNC | MCC | EPC | EcCentricity |
---|---|---|---|---|---|
(A) Upregulated | |||||
Gene symbol | AURKA | AURKA | AURKA | AURKA | AURKA |
MAD2L1 | MAD2L1 | MAD2L1 | TRIP13 | TRIP13 | |
CCNB2 | CCNB2 | CCNB2 | CCNB2 | CCNB2 | |
BIRC5 | BIRC5 | BIRC5 | PHGDH | PHGDH | |
BUB1 | BUB1 | BUB1 | BUB1 | BUB1 | |
UBE2C | UBE2C | UBE2C | UBE2C | UBE2C | |
TYMS | TYMS | PTTG1 | CDC45 | CDC45 | |
CDK1 | CDK1 | CDK1 | CDK1 | CDK1 | |
MYC | MYC | CDC45 | MYC | MYC | |
CDC20 | CDC20 | CDC20 | CDC20 | CDC20 | |
(B) Downregulated | |||||
Gene symbol | ESR1 | ESR1 | ESR1 | FOXA1 | PIP |
CCND1 | CCND1 | FOXA1 | ESR1 | AR | |
AR | TFF1 | TFF1 | GATA3 | ESR1 | |
TFF1 | AR | GATA3 | TFF1 | GATA3 | |
FOXA1 | FOXA1 | TFF3 | CCND1 | MUC1 | |
GATA3 | GATA3 | CCND1 | AR | AZGP1 | |
AGR2 | MUC1 | AGR2 | AGR2 | FOXA1 | |
MUC1 | TFF3 | XBP1 | MUC1 | IGF1R | |
PIP | AGR2 | AGR3 | TFF3 | TFF1 | |
TFF3 | PIP | SLC39A6 | XBP1 | MYB | |
(C) Upregulated | |||||
Gene symbol | HIST2H2AC | ERBB2 | HIST2H2AC | HIST2H2BE | KLK6 |
HIST1H4H | HIST2H2BE | HIST1H4E | HIST2H2AC | RBP1 | |
ERBB2 | HIST2H2AC | HIST2H4A | HIST1H4E | CX3CL1 | |
HIST2H2BE | CDH1 | HIST1H2BD | HIST1H2BK | CCL2 | |
HIST1H4E | HIST1H4E | HIST2H2AA3 | CDH1 | SDC1 | |
CCL2 | HIST2H4A | HIST1H4H | HIST2H4A | MYC | |
MYC | MYC | HIST1H3D | HIST1H2BD | FOS | |
HIST2H4A | HIST1H4H | HIST1H3H | MYC | CDH1 | |
FOS | FOS | HIST1H2AE | HIST1H4H | LTF | |
CDH1 | CCL2 | HIST1H1C | FOS | APP |
A/B: Hub genes detected for the DEGs in the up- and downregulated PPI networks, respectively. C: Hub genes detected for the PPI network with DEGs expressed in hormone-positive (HR+) breast cancer patients only.